Over a Million Americans Are Rationing Insulin Due to High Cost
TUESDAY, Oct. 18, 2022 (HealthDay News) — More than 1 million Americans with diabetes have to ration lifesaving insulin because they can’t afford it, a new study shows.Many people delayed picking up their insulin prescription, while others took lower…
Learn MoreUnos estudios de gran tamaño evalúan la efectividad de unos medicamentos comunes para la diabetes
JUEVES, 22 de septiembre de 2022 (HealthDay News) — Dos medicamentos comunes para la diabetes parecen funcionar mejor que otros dos respecto al control de los niveles de azúcar en la sangre, encontró un gran ensayo de EE. UU.El ensayo, con más de 5,0…
Learn MoreBig Studies Test Effectiveness of Common Diabetes Meds
THURSDAY, Sept. 22, 2022 (HealthDay News) — Two common diabetes medications seem to outperform two others when it comes to controlling blood sugar levels, a large U.S. trial has found.The trial of more than 5,000 people with type 2 diabetes found tha…
Learn MoreExperimental Insulin-in-a-Pill Shows Promise in Rat Study
MONDAY, Sept. 5, 2022 (HealthDay News) – People with type 1 diabetes who need to inject insulin a few times a day could eventually be switching to an easier-to-take tablet that dissolves inside the cheek. Canadian researchers working with rodents repo…
Learn MoreCiertos analgésicos aumentan el riesgo de insuficiencia cardiaca en las personas con diabetes tipo 2
MIÉRCOLES, 24 de agosto de 2022 (HealthDay News) — Las personas con diabetes tipo 2 podrían enfrentarse a un aumento sustancial en el riesgo de insuficiencia cardiaca si toman ibuprofeno o algún otro tipo de antiinflamatorio no esteroide (AINE), indi…
Learn MoreCertain Painkillers Raise Heart Failure Risk in People With Type 2 Diabetes
WEDNESDAY, Aug. 24, 2022 (HealthDay News) — People with type 2 diabetes might face a substantially increased risk of heart failure if they take ibuprofen or some other type of nonsteroidal anti-inflammatory drug (NSAID), a new Danish study indicates….
Learn MoreJanuvia, un medicamento común para la diabetes, podría contener vestigios de un cancerígeno, señala la FDA
VIERNES, 12 de agosto de 2022 (HealthDay News) — Januvia, un popular fármaco para la diabetes, podría contener vestigios de un probable carcinógeno, pero los pacientes deben seguir usando el medicamento, porque dejar de tomarlo podría resultar peligr…
Learn MoreCommon Diabetes Drug Januvia May Contain Traces of Carcinogen, FDA Says
FRIDAY, Aug. 12, 2022 (HealthDay News) – The popular diabetes drug Januvia may contain traces of a probable carcinogen, but patients should keep using the medication because it could be dangerous to stop taking it, the U.S. Food and Drug Administratio…
Learn More